skip to Main Content

News

Istari Oncology to Participate in Upcoming Virtual Investor Conferences

DURHAM, NC – September 7, 2021 – Istari Oncology, Inc., a clinical-stage biotechnology company focused…

read more

Istari Oncology Initiates Its Phase I/II Sub-Study Evaluating PVSRIPO in Patients with Head and Neck Cancer

DURHAM, NC – August 17, 2021 – Istari Oncology, Inc., a clinical-stage biotechnology company focused…

read more

Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma

Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced…

read more

Istari Oncology to Present Data from its PVSRIPO Immunotherapy Platform at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

Istari Oncology to Present Data from its PVSRIPO Immunotherapy Platform at the American Society of…

read more

Istari Oncology Honored as “Best Early Stage Product Development Company” in the Triangle Business Journal’s Life Sciences Awards

Istari Oncology Honored as "Best Early Stage Product Development Company" in the Triangle Business Journal's…

read more

Istari Oncology Announces Publication of Phase 1 Data Showing PVSRIPO Immunotherapy Leads to Objective Responses in Patients with Treatment-Refractory Melanoma

Istari Oncology Announces Publication of Phase 1 Data Showing PVSRIPO Immunotherapy Leads to Objective Responses…

read more

Istari Oncology Announces FDA Clearance of IND to Initiate LUMINOS-103

Istari Oncology Announces FDA Clearance of IND to Initiate LUMINOS-103: A Basket Trial Evaluating the…

read more

Istari Oncology Abstracts to be Presented at the American Association for Cancer Research 2021 Annual Meeting

Istari Oncology Abstracts to be Presented at the American Association for Cancer Research (AACR) 2021…

read more

Istari Oncology Announces First Patient Dosed in the LUMINOS-102 Phase 2 Clinical Trial of PVSRIPO

Istari Oncology Announces First Patient Dosed in the LUMINOS-102 Phase 2 Clinical Trial of PVSRIPO…

read more
Back To Top
×Close search
Search